Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2251052 versus imipenem-cilastatin for febrile complicated lower urinary tract infection and acute pyelonephritis
2011-000484-28Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of epetraborole in complicated urinary tract infection (cUTI) and acute pyelonephritis (2 arms), sponsored by GSK. Started Apr 2011; status: completed.
02
Drugs
epetraborole
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on 2011-000484-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000484-28.